← SynDRA
GRAPIPRANT
SynDRA canonical compound SYN0037746 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PTGER4 |
|---|
| Mechanism of action | prostaglandin inhibitor |
|---|
| Indication | osteoarthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- PTGER4 ANTAGONIST
- Prostanoid EP4 receptor antagonist
- prostaglandin inhibitor
Cross-references
Synonyms
- RQ-7
- RQ-00000007
- MR10A7
- AAT-007
- CJ-023423
- Cj-023,423
- 423
- CJ-023
- MR-10A7
- Galliprant
- RQ-00000007 (oral)
- RQ-00000007 (iv)
- MR-10-A-7
- IK-007
- CJ 023,423
- J9F5ZPH7NB
- CJ 023423
- grapiprantum
- RefChem:57297
- DTXCID20116910
- RQ-07
- CJ023,423
- CJ-023423 Hydrochloride Salt, Hydrate
- CJ-023423;RQ-00000007;AAT-007
- Grapiprant [USAN:INN]
- UNII-J9F5ZPH7NB
- Grapiprant (CJ-023423)
- Grapiprant?
- C26H29N5O3S
- MFCD16628076
- A1ECR
- GRAPIPRANT [MI]
- GRAPIPRANT [INN]
- Grapiprant (USAN/INN)
- GRAPIPRANT [USAN]
- GRAPIPRANT [WHO-DD]
- SCHEMBL120428
- GTPL5858
Look up GRAPIPRANT in the interactive SynDRA portal →